In Brief This Week: Sequenom; Promega; Danaher; Agilent; Horizon Discovery; Silicon Biosystems; Warnex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom this week said that the American Journal of Obstetrics and Gynecology has accepted for publication a manuscript that details the results of the firm's "locked-assay" study on its Trisomy 21 test. It did not provide a planned date for the article.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.